Quercetin and Inflammaging: The Root Cause of Ageing Most Supplements Ignore
You've heard that inflammation is bad. What most people don't realise is that there are two completely different kinds — and only one of them is killing you slowly.
Acute inflammation is your immune system doing its job: responding to an injury, fighting an infection, then standing down. That's healthy. The problem is the other kind — the low-grade, persistent, smouldering inflammation that never fully switches off as you age. Scientists call it inflammaging, and it's now considered one of the primary drivers of most age-related disease.
NMN Bio's Quercetin 250mg was formulated specifically to address this mechanism — not with a broad-spectrum anti-inflammatory blunderbuss, but by targeting the molecular pathway at the root of the problem.
What Is Inflammaging?
The term was coined by Italian gerontologist Claudio Franceschi in the early 2000s, and the concept has since become central to longevity science. Inflammaging describes the age-related shift toward a chronically pro-inflammatory state — not enough to cause obvious symptoms, but enough to accelerate tissue damage across every organ system over decades.
The sources are multiple and they compound each other. Senescent cells — cells that have stopped dividing but refuse to die — secrete a toxic cocktail of inflammatory signals called the Senescence-Associated Secretory Phenotype (SASP). Damaged mitochondria leak reactive oxygen species. Gut barrier function deteriorates, allowing bacterial fragments to enter circulation. Cellular debris accumulates faster than the body can clear it. Each source feeds the others.
The result is a background fire that never goes out. And over time, that fire accelerates cardiovascular disease, neurodegeneration, metabolic dysfunction, and cancer risk. Franceschi's own research, along with decades of subsequent work, shows that inflammatory markers like IL-6 and CRP are among the strongest predictors of biological age and all-cause mortality.
NF-kB: The Switch That Keeps the Fire Burning
At the centre of inflammaging is a transcription factor called NF-kB (Nuclear Factor kappa-light-chain-enhancer of activated B cells). It functions as the master regulator of the inflammatory response — when activated, it drives the production of pro-inflammatory cytokines including IL-1β, IL-6, and TNF-α. These are the signalling molecules that sustain the chronic inflammatory state.
NF-kB activity increases with age. Senescent cells amplify it. Oxidative stress activates it. And once the cycle starts, it self-perpetuates.
This is where quercetin becomes genuinely interesting. Quercetin inhibits IκB kinase (IKK) — the enzyme that phosphorylates and degrades IκB, the protein that normally keeps NF-kB locked in the cytoplasm. By blocking IKK, quercetin prevents NF-kB from translocating to the nucleus. Without nuclear NF-kB, the downstream production of IL-1β, IL-6, and TNF-α is significantly reduced. That's not a vague anti-inflammatory effect — it's a specific intervention at an identified mechanism.
The SASP Problem — and Quercetin's Two-Pronged Response
Senescent cells are particularly important in the inflammaging story. They accumulate with age in tissues throughout the body, and their SASP output is one of the primary sources of chronic inflammatory signalling. Standard anti-inflammatory approaches don't address this — they suppress the downstream symptoms without touching the cells producing them.
Quercetin is unusual because it acts on both fronts. It functions as a senolytic — it selectively clears senescent cells by disrupting the pro-survival pathways (particularly PI3K/AKT) that allow them to resist apoptosis. And it functions as a senomorphic — in cells that remain, it suppresses SASP output via NF-kB inhibition.
That's a meaningful distinction. Most senolytics clear cells. Quercetin also quiets the ones it doesn't clear. The combination reduces the total inflammatory burden from senescent tissue more effectively than either action alone.
Quercetin vs. NSAIDs — Not the Same Game
The standard response to inflammation in Western medicine is NSAIDs: ibuprofen, aspirin, naproxen. These work by inhibiting COX enzymes, which reduces prostaglandin synthesis and blunts the inflammatory response systemically. They're effective for acute pain and fever. For the chronic, age-related kind of inflammation? They're a poor fit.
NSAIDs don't discriminate. They suppress protective prostaglandins in the gut lining along with the inflammatory ones, which is why long-term use is associated with GI bleeding, ulcers, and — particularly with COX-2 inhibitors — increased cardiovascular risk. They don't touch NF-kB. They don't address SASP. They don't clear senescent cells.
Quercetin's safety profile, by contrast, is well-established across human trials at doses up to 1,000mg daily with no significant adverse effects. It acts selectively at the pathway level, not as a blanket enzyme inhibitor. For addressing the chronic, systemic inflammation of ageing rather than an acute injury, the comparison isn't close.
The Absorption Problem Most Formulations Ignore
Standard quercetin has a bioavailability problem. In isolation, it's a relatively unstable polyphenol that oxidises during absorption in the gut — and that oxidation generates free radicals. The irony is significant: a supplement taken to reduce oxidative stress and inflammaging can actually contribute to the problem if the formulation is wrong.
NMN Bio's Quercetin 250mg is formulated with Vitamin C and citrus bioflavonoids specifically to address this. Vitamin C is a potent reducing agent that stabilises quercetin during absorption, preventing the oxidative degradation that compromises both bioavailability and safety. The citrus bioflavonoids act synergistically — they share absorption pathways with quercetin and have been shown to enhance its uptake. The result is a formulation where each capsule delivers full-potency quercetin to circulation, not an oxidised fraction of what was on the label.
This matters more as the bottle ages. Standard quercetin formulations degrade over time. The stabilised formula means the last capsule in the bottle works as well as the first.
Quercetin + NMN: Hitting Inflammaging from Two Directions
NMN raises NAD+ levels, which supports sirtuin activity — specifically SIRT1 and SIRT3. SIRT1 is a direct negative regulator of NF-kB: it deacetylates the p65 subunit of NF-kB, reducing its transcriptional activity. Higher NAD+ means more active SIRT1 means less NF-kB signalling.
Quercetin inhibits NF-kB via IKK. NMN suppresses NF-kB activity via SIRT1. They operate through different molecular pathways that converge on the same target. That's not redundancy — it's complementary pressure on the most important inflammatory switch in the ageing body.
The combination also covers the SASP problem from both ends: quercetin clears and quiets senescent cells directly, while NMN supports the mitochondrial health and autophagy processes that reduce the rate of cellular senescence in the first place.
Inflammaging isn't dramatic. It doesn't announce itself. It just chips away at every system, year after year, until the cumulative damage becomes impossible to ignore. Targeting it upstream — at NF-kB, at senescent cells, at the molecular mechanisms that sustain the chronic fire — is a different category of intervention to taking a general-purpose antioxidant and hoping for the best.
The Rejuvenation Bundle — NMN, TMG, Quercetin, and Berberine — combines the key compounds that target inflammaging, NAD+ decline, and metabolic ageing together. If you're serious about addressing the root mechanisms rather than the symptoms, this is where to start.
Dr Seranova holds a master's degree in Translational Neuroscience from the University of Sheffield, UK, and a Ph.D in Stem Cell Biology and Autophagy from the University of Birmingham, UK. She is a published author in multiple peer-reviewed journals, including Cell Reports and Developmental Cell. All content on our website is put together by NMN Bio's scientific team and reviewed by Dr Elena Seranova.
Leave a comment